3.10
+0.05(+1.64%)
Currency In USD
| Previous Close | 3.05 |
| Open | 3.13 |
| Day High | 3.13 |
| Day Low | 3.1 |
| 52-Week High | 552.5 |
| 52-Week Low | 2.61 |
| Volume | 18,181 |
| Average Volume | 646,743 |
| Market Cap | 1.62M |
| PE | 0 |
| EPS | 2,044.06 |
| Moving Average 50 Days | 3.37 |
| Moving Average 200 Days | 19.09 |
| Change | 0.05 |
If you invested $1000 in Onconetix, Inc. (ONCO) since IPO date, it would be worth $0.02 as of September 15, 2025 at a share price of $3.1. Whereas If you bought $1000 worth of Onconetix, Inc. (ONCO) shares 2 years ago, it would be worth $1.42 as of September 15, 2025 at a share price of $3.1.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Onconetix and Ocuvex Therapeutics announce execution of definitive merger agreement
GlobeNewswire Inc.
Jul 16, 2025 12:17 PM GMT
CINCINNATI, July 16, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc. (Nasdaq: ONCO) (“Onconetix” or the “Company”) and Ocuvex Therapeutics, Inc. (“Ocuvex”), a privately held biopharmaceutical company focused on the development and commercialization of oph
Onconetix, Inc. Announces Positive Decision by Nasdaq Hearings Panel
GlobeNewswire Inc.
Jun 16, 2025 12:22 PM GMT
CINCINNATI, Ohio, June 16, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc. (Nasdaq: ONCO) (“Onconetix” or the “Company”), a commercial-stage biotechnology company focused on the research, development, and commercialization of innovative solutions for men
Onconetix, Inc. Announces 1-for-85 Reverse Stock Split and Results of the Special Meeting of Stockholders
GlobeNewswire Inc.
Jun 11, 2025 3:30 PM GMT
CINCINNATI, Ohio, June 11, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc. (NASDAQ: ONCO) (“Onconetix” or the “Company”), a commercial-stage biotechnology company focused on the research, development, and commercialization of innovative solutions for men